18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors
Phase of Trial: Phase I
Latest Information Update: 02 May 2018
At a glance
- Drugs F-18 fluorothymidine (Primary) ; Fluciclovine 18F (Primary)
- Indications CNS cancer; Glioma; Tumours
- Focus Diagnostic use
- 26 Mar 2018 Status changed from active, no longer recruiting to completed.
- 19 Jan 2018 Planned End Date changed from 1 Jan 2018 to 1 Jan 2019.
- 19 Jan 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Jan 2019.